- Home
- RA vs BVS Comparison
RA vs BVS Comparison
Compare RA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RA | BVS |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 702.3M | 716.8M |
| IPO Year | 2016 | 2016 |
Fundamental Metrics
Financial Performance| Metric | RA | BVS |
|---|---|---|
| Price | $12.93 | $10.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 139.3K | ★ 635.4K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ N/A | $246.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.50 | $5.81 |
| 52 Week High | $13.59 | $11.25 |
Technical Indicators
Market Signals| Indicator | RA | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 62.43 | 65.38 |
| Support Level | $12.83 | $8.42 |
| Resistance Level | $13.02 | $11.00 |
| Average True Range (ATR) | 0.11 | 0.39 |
| MACD | 0.04 | 0.17 |
| Stochastic Oscillator | 93.69 | 98.01 |
Price Performance
Historical ComparisonAbout RA Brookfield Real Assets Income Fund Inc.
Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. The investment objective of the Fund is to seek high total return, through high current income and secondarily, through growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities, Infrastructure Securities, and Natural Resources Securities. The Fund operates in a single operating segment.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.